Last $4.20 USD
Change Today -0.07 / -1.64%
Volume 128.3K
BTX On Other Exchanges
BTX is not on other exchanges.
As of 8:04 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

biotime inc (BTX) Key Developments

BioTime Seeks Acquisitions

BioTime, Inc. (AMEX:BTX) has filed a shelf registration in the amount of $100 million. BioTime said, "We intend to use the net proceeds from the sale of our securities offered by this prospectus for general corporate purposes, including, without limitation, working capital, capital expenditures, research and development expenditures, regulatory affairs expenditures, clinical trial expenditures, acquisitions of new technologies and businesses, and investments, including in our subsidiaries."

Aditya Mohanty Joins BioTime, Inc. as New Chief Operating Officer

On December 29, 2014, Aditya Mohanty joined BioTime, Inc. as its new Chief Operating Officer. Mr. Mohanty comes to the company from Shire plc, where he served in a number of executive positions, including as President/Head Regenerative Medicine from 2013 to 2014, as Senior Vice President, Business and Technical Operations from 2012 to 2013, as Global Franchise Head MPS from 2010 to 2012, and as Vice President of Operations/Product General Manager from 2005 to 2012. Mr. Mohanty was VP of Manufacturing and Operations at Transkaryotic Therapies, Inc. from 2002 to 2005 when it was acquired by Shire. Before joining Transkaryotic Therapies, Mr. Mohanty held a number of management positions at Baxter Healthcare Corporation, Bioscience Division from 1990 to 2002.

BioTime, Inc. Appoints Angus C. Russell to Board of Directors

BioTime, Inc. announced that Angus C. Russell, former Chief Executive Officer of Shire plc, has been appointed to BioTime's Board of Directors. He currently serves on the boards of directors of Mallinckrodt plc and Revance Therapeutics, Inc.

BioTime, Inc. - Analyst/Investor Day

To discuss an overview of company’s growth opportunities and operational strategy

BioTime, Inc. Presents at LD Micro Conference, Dec-04-2014 04:00 PM

BioTime, Inc. Presents at LD Micro Conference, Dec-04-2014 04:00 PM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States. Speakers: Michael D. West, Chief Executive Officer, President and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $4.20 USD -0.07

BTX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Athersys Inc $2.59 USD +0.02
Geron Corp $3.02 USD -0.13
Neuralstem Inc $3.76 USD -0.02
Ocata Therapeutics Inc $7.22 USD -0.03
Organovo Holdings Inc $5.92 USD -0.14
View Industry Companies

Industry Analysis


Industry Average

Valuation BTX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 54.3x
Price/Book 38.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 59.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at